GLP-1 without insurance: compare the real cash-pay path

For branded Zepbound, LillyDirect lists a 28-day supply at $299 for 2.5 mg and $399 for 5 mg. Under the Zepbound Self Pay Journey Program, the listed price is $449 for 7.5 mg, 10 mg, 12.5 mg, or 15 mg. To retain that $449 price, the next purchase must be completed within 45 days of receiving the previous supply. Missing that window can trigger the regular price, which Lilly currently lists from $499 to $699 depending on the dose. Taxes or other fees may apply. Lilly’s current terms say the offer can be changed or ended at any time.

NovoCare lists Wegovy pens at $199 per 28-day supply for the first two monthly fills (the 0.25 mg and 0.5 mg starter doses) for qualifying new patients through December 31, 2026. The standard self-pay price is then $349 for the 0.25 mg through 2.4 mg pens and $399 for Wegovy HD. A prescription and program eligibility are required. NovoCare’s offer page also warns that the program may be modified or canceled.

These prices cover the medication through the designated program. They do not automatically include an outside clinician, laboratory work, or a telehealth membership. Ask the dispensing pharmacy to confirm the amount due before each shipment because promotional eligibility and refill timing can affect the charge.

NovoCare’s oral Wegovy offer lists a 30-tablet supply at $149 for the 1.5 mg strength. The 4 mg strength is also $149 under a limited offer through August 31, 2026, after which NovoCare lists it at $199. The standard self-pay prices for the 9 mg and 25 mg strengths are $299 per 30-tablet bottle. These amounts are processed outside insurance and are subject to the program’s eligibility rules. NovoCare publishes the strength-by-strength table.

LillyDirect also lists cash prices for Foundayo, an oral GLP-1 approved by FDA in April 2026. As of July 2026, the published monthly prices are $149 for 0.8 mg, $199 for 2.5 mg, and $299 for 5.5 mg or 9 mg. The 14.5 mg and 17.2 mg strengths are $299 when the program’s 45-day refill condition is met; Lilly lists a regular price of $349 for those strengths when it is not. The Foundayo terms define a month as 30 days and allow Lilly to change or terminate the offer.

A low introductory oral price is not necessarily the long-term price. Compare the likely recurring strength, the number of fills covered by a promotion, and the price after the promotion—not just the first bottle.

A telehealth quote can contain several separate charges: the clinical membership, the medication, laboratory testing, and sometimes shipping or administrative fees. The provider’s large headline price may describe only one of them.

Ro’s published pricing illustrates the split. As of July 2026, its Body membership is $39 for the first month, $149 month to month afterward, or as low as $74 per month when an annual plan is prepaid. Medication is billed separately. Ro says the membership includes ongoing provider support, check-ins, coaching, insurance assistance, and laboratory testing when necessary. Its pricing page also states that prepaid savings require paying for multiple months in advance.

Do not compare a manufacturer’s medication-only price with a telehealth membership-plus-medication total as if they were equivalent. Request an itemized quote showing the first charge, the normal recurring charge, the medication price at later strengths, which labs are included, shipping costs, and what happens to unused prepaid months if you leave.

A compounded GLP-1 may produce the lowest-looking advertisement because it is not the branded, FDA-approved product. FDA states that compounded drugs are not reviewed for safety, effectiveness, or quality before marketing. FDA also warns telehealth companies not to call a compounded drug “generic” or imply that it is the same as an approved product. A claim that a pharmacy is “FDA-approved” or “FDA-licensed” is also misleading because FDA does not approve or license pharmacies. FDA explains these advertising distinctions.

The verification burden is practical, not theoretical. FDA has reported compounded GLP-1 products carrying false pharmacy information and dosing errors involving injectable semaglutide. It also says semaglutide sodium and semaglutide acetate are different active ingredients from the one used in approved semaglutide drugs. FDA’s GLP-1 compounding page recommends buying only through state-licensed pharmacies.

Before paying, obtain the exact drug name, formulation, concentration, dispensing pharmacy’s legal name and address, pharmacy license information, prescriber’s name, and a written explanation of how questions or adverse events are handled. If the seller will not identify the actual compounder before checkout, the price cannot be meaningfully evaluated.

Manufacturer savings programs are contracts with eligibility limits, maximum savings, expiration dates, and refill rules. Lilly’s Zepbound commercial savings-card terms require a qualifying prescription and commercial drug insurance and exclude people enrolled in Medicare, Medicaid, TRICARE, VA coverage, and other government-funded programs. The separate self-pay purchase offer has its own conditions, so the phrase “savings card” should not be treated as interchangeable with “cash program.”

NovoCare likewise separates commercial-insurance copay assistance from self-pay pricing. Its published Wegovy terms say self-pay transactions run outside insurance and cannot be submitted for reimbursement or credited toward insurance deductibles or out-of-pocket limits. Before relying on any offer, check the current terms for your insurance category, prescribed product and pharmacy channel. Never assume that an eligibility result for one manufacturer applies to another.

Get the complete financial arrangement in writing. A useful quote covers at least the next six months, not merely the checkout charge. It should identify who bills you, when each subscription renews, and whether the medication price changes with strength or after an introductory period.

FDA says a safer online pharmacy requires a prescription, provides a US address and phone number, has a licensed pharmacist available, and is licensed by a state pharmacy board. Deep discounts, no prescription requirement, no pharmacist, or no identifiable US pharmacy are warning signs. FDA’s online-pharmacy checklist supports walking away when those basics cannot be confirmed.

Bring the itemized price, program terms, product label, pharmacy information, medication list, and questions about follow-up to the appointment. That gives the clinician concrete information to review instead of a promotional screenshot.

A seller that pressures you to pay before identifying the prescriber, pharmacy, or exact product has not supplied enough information for an informed purchase. Direct medication and health decisions to a licensed clinician who knows your medical history.

When shopping for GLP-1s without insurance, treat medication price and any platform or membership fees as separate line items. Some manufacturer or pharmacy programs publish a cash-pay price for the drug itself; separate telehealth or weight-loss companies may add monthly or program fees that are not included in the medication price. Always ask for an itemized quote showing medication cost, dispensing/pharmacy fees, and any subscription or clinician-visit charges before enrolling.

Some manufacturers and specialty pharmacies publish publicly available cash-pay prices or program terms. For example, NovoCare (Novo Nordisk's pharmacy program) publishes cash-pay pharmacy pricing and terms related to Wegovy access programs. Similarly, Lilly publishes dose-specific cash-pay pricing and terms for Zepbound. These published pages are useful for getting a baseline medication price without insurance, but they represent one piece of the total cost picture and may be updated by the company.

Many online weight-loss companies and telehealth services publish both program membership pricing and notes about medication costs. For example, Ro and Hims publish program pricing on their websites; their stated prices can include membership tiers, coaching, or visit fees and may be separate from the cost of the GLP-1 medication. When comparing options, ask the provider to break out: (1) the medication cost, (2) any membership or monthly fee, and (3) clinic visit or lab costs. That way you can compare like-for-like between a direct pharmacy cash-pay price and a bundled telehealth program.

The FDA has issued clear warnings about unapproved GLP-1 products marketed for weight loss. These products may be mislabeled, sold as research-only or not-for-human-use, and have led to dosing errors and adverse events. Compounded products and imports that are not FDA-approved lack the same manufacturing oversight, potency verification, and approved labeling as brand medications. If a pharmacy or seller offers a GLP-1 product that is not an FDA-approved brand, ask for documentation of testing and review the FDA's alerts before purchasing.

To estimate what you'll actually pay without insurance, follow a consistent checklist: 1) Identify the exact medication and dose you were prescribed. 2) Get the manufacturer or specialty pharmacy cash-pay price page for that product when available. 3) If using a telehealth platform, request a written itemized cost: medication, membership, visits, labs, and shipping. 4) Confirm whether the posted prices are per-month, per-pen, or per-package and how many doses that covers. 5) Ask the pharmacy or program about discount coupons, manufacturer patient assistance programs, or co-pay cards that apply to cash-pay customers.

Clinical oversight matters. Legitimate programs should assess your medical history, review medications and contraindications, and arrange appropriate labs or follow-up. Do not rely on vendors who claim easy access without any medical screening. Also, avoid sellers who pressure you to bypass standard monitoring or who cannot document a licensed prescriber's involvement. Finally, remember that we cannot provide dosing instructions - those come from your treating clinician.

Manufacturers may offer support programs that include information about access options and sometimes financial assistance or savings programs for eligible patients. Published specialty pharmacy pages or manufacturer pricing pages are the place to start if you are uninsured and seeking a cash-pay route. Use those pages to confirm the medication cash-pay price and then compare to any telehealth or clinic total cost. Keep in mind program eligibility and terms can change, so verify current details on the company site.

Before you commit to any out-of-pocket purchase, ask the seller these questions: Is the product FDA-approved under the brand name you were prescribed? If not, can you see batch testing and stability records? Does the price quote include clinician visits, labs, or is that extra? Who is the licensed prescriber, and will you have documented follow-up? Are there written policies for adverse events and returns? Avoid vendors that cannot clearly answer these items.